NIMRODS Box Office Recap and FAQ
NIMRODS is officially in theaters, and it's time for our opening weekend box office recap. We're laying it out FAQ-style so you can jump straight to whatever you're most curious about.
How are the reviews?
The movie has been very well received. Our Rotten Tomatoes score is 75% / 94% (critics/audience), and our Letterboxd score is 3.6 with nearly 12,000 reviews. We’ve had the opportunity to watch this movie with hundreds of Legion M investors, and the feedback from them has all been very positive. I think it’s a movie we can all be very proud to have as part of our portfolio.
What are the numbers?
Inaugural (our release partner) hasn't officially reported yet, but we can share some unofficial figures: over its opening weekend (including the Tuesday night advance screenings), NIMRODS earned $910,110 from 1,012 theaters — a per-theater average of just under $900. Note that not all of these screens had full schedules – over 50% had “split schedules” with less than 5 shows a day. See below for more about that.
Is that good or bad?
Honestly? It's in the middle. We always want more — and we always will — but it could have been much, much worse. For context, here's how NIMRODS stacks up against our last three theatrical releases:
As you can see, NIMRODS delivered our biggest opening weekend yet and our second-highest per-theater average. We weren’t a hit, but didn’t flop. In the context of independent film releasing in 2026, this result is about par.
What’s Legion M’s role in Nimrods?
We invested alongside with Inaugural Entertainment as a distribution partner, rallied the Legion M community, managed several promotional initiatives, helped support the premiere in multiple ways, and generally plugged in wherever we could add value. We put up about 25% of the money (via the Film Fund) to release the film, and will receive about the same % share of net revenue received by distribution. First dollars go to Film Fund investors until they’ve recouped principle and profit – everything after that is retained by Legion M.
What does this mean for Film Fund investors?
It's a decent result. Costs on this release are comparable to Fackham Hall, and NIMRODS opened roughly 45% ahead of Fackham Hall at the box office, so we're ahead at this stage. That said, the SVOD deals on the two films are different, which means — like many independent films in 2026 — the battle for profitability will be won or lost on VOD. And we’ve got a lot of reasons to be optimistic about that.
Either way, the "last-in, first-out" structure of the Film Fund means NIMRODS revenue flows to Film Fund investors first. There’s still risk, but we believe Film Fund investors are well positioned to recoup their principal and receive full profits from NIMRODS over time.
BTW, there’s still time to invest in NIMRODS via the Film Fund, but the offering is close to sold out. For more information, please check out the offering page.
What does this mean for Legion M investors?
Legion M participates alongside the Film Fund in the economics of this project. While the Film Fund investors get paid first, their upside is capped. Profits beyond that cap are retained by Legion M for the life of the distribution contract. While it’s too early to know for sure, we believe Legion M is well positioned to earn back our investment, plus a premium, and create another ongoing revenue stream for the company.
This is all in addition to the strategic value the project creates for Legion M. Like so many of our previous projects, it has allowed us to grow our community and level-up our capabilities as we continue our march to make it to the top of the mountain!
Theaters are busy right now. Is that good or bad?
Both! The box office is VERY strong at the moment. Spider-Man: Brand New Day and The Odyssey are both enjoying historically strong runs. This is great for the industry, great for theaters, and great for fans.
That said, for smaller films releasing at the same time, it makes screens harder to come by.
Case in point: because of the competition, about half of our 1,012 theaters gave NIMRODS a "split schedule." Instead of owning a screen outright with five showtimes a day, NIMRODS got two or three. Split-schedule ticket sales still count toward our topline number – two or three showtimes is better than none – but they can also drag down our per-theater average, which can make it harder to hold onto screens.
Bottom line – we’d rather the box office be busy than dying. It makes for greater competition, but we think that’s a good thing.
Where does NIMRODS go from here?
Competition for screens is still fierce. Next week brings seven more wide releases — Insidious: Out of the Further, The Magic Faraway Tree, Mutiny, Spa Weekend, Teenage Sex and Death at Camp Miasma, the 25th-anniversary re-release of The Fast and the Furious, and Tony — plus the moderate release Hot Spot (800 runs) and two Hindi titles. On top of that, Spider-Man: Brand New Day and The Odyssey continue to dominate, combining for roughly $101 million this weekend alone.
Every multiplex in the country is deciding which films keep a screen and which have to go. Our theatrical team is fighting tooth and nail to hold as many as we can, but we're clear-eyed about expectations. We should know more later this week.
In the meantime we'll have more to share about the VOD release soon, and we're hopeful the momentum — and the genuinely good word of mouth on this movie — carries through.
Got questions?
Just email team@legionm.com. We may work your question into the next update.
And gear up — our next release is right around the corner. The first screenings of Coyote vs. Acme start Sunday, and the movie opens wide next week!
Onward and upward!
Round 11: RISK VS REWARD: Startup investments like Legion M are speculative, illiquid, and involve a high degree of risk. Statistically, most startups fail, so you should never invest more than you can afford to lose. But if you’d like to take a swing at making history, we’d love to have you aboard our moonshot!
This Reg CF offering is made available through StartEngine Primary LLC, member FINRA/SIPC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Film Fund: Equity crowdfunding investments in private placements are speculative and involve a high degree of risk. Those investors who cannot afford to lose their entire investment should not invest. Companies seeking investment through equity crowdfunding tend to be in earlier stages of development and their business model, products and services may not yet be fully developed, operational or tested in the public marketplace. There is no guarantee that the terms are accurate or in agreement with the market or industry valuations. Legion M Film Fund - 1099, LLC has filed a Form C with the Securities and Exchange Commission in connection with its offering, a copy of which may be obtained here.
DealMaker Securities LLC, a registered broker-dealer, and member of FINRA | SIPC, located at 30 East 23rd Street, 2nd Floor, NY, NY 10010, is the Intermediary for this offering and is not an affiliate of or connected with the Issuer. Please check our background on FINRA's BrokerCheck. DealMaker Securities LLC does not make investment recommendations.
DealMaker Securities LLC is NOT placing or selling these securities on behalf of the Issuer. DealMaker Securities LLC is NOT soliciting this investment or making any recommendations by collecting, reviewing, and processing an Investor's documentation for this investment. DealMaker Securities LLC conducts Anti-Money Laundering, Identity and Bad Actor Disqualification reviews of the Issuer, and confirms they are a registered business in good standing. DealMaker Securities LLC is NOT vetting or approving the information provided by the Issuer or the Issuer itself. Contact information is provided for Investors to make inquiries and requests to DealMaker Securities LLC regarding Regulation CF in general, or the status of such investorʼs submitted documentation, specifically. DealMaker Securities LLC may direct Investors to specific sections of the Offering Circular to locate information or answers to their inquiry but does not opine or provide guidance on issuer related matters.